| Literature DB >> 11395311 |
S Y Lee1, Y S Choe, D H Kim, B N Park, S E Kim, Y Choi, K H Lee, J Lee, B T Kim.
Abstract
In vitro metabolism of acetylcholinesterase inhibitors containing 3-[(18)F]fluoromethylbenzyl- ([(18)F]1) and 4-[(18)F]fluorobenzyl-piperidine moieties ([(18)F]2) was studied and compared with the in vivo metabolism. Defluorination of the [(18)F]1 mainly occurred to generate [(18)F]fluoride ion both in vitro and in vivo. In contrast, the [(18)F]2 was converted into an unknown polar metabolite in both metabolism methods and another metabolite, 4-[(18)F]fluorobenzoic acid in vitro. These results demonstrated that the in vitro method can be used to predict the in vivo metabolism of both radiotracers.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11395311 DOI: 10.1016/s0969-8051(01)00203-7
Source DB: PubMed Journal: Nucl Med Biol ISSN: 0969-8051 Impact factor: 2.408